BSI never asked for RCT data. They asked for 20 supplementary patients. Oncosil delivered 42. Oncosil has done more then they were asked. Plus Oncosil have presented their data to over a dozen conferences all over the world plus they have had their data published in academic and scientific journals.
- Forums
- ASX - By Stock
- What happened to FDA approval?
OSL
oncosil medical ltd
Add to My Watchlist
3.09%
!
$1.00

BSI never asked for RCT data. They asked for 20 supplementary...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.00 |
Change
0.030(3.09%) |
Mkt cap ! $14.22M |
Open | High | Low | Value | Volume |
99.5¢ | $1.00 | 96.0¢ | $39.65K | 40.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 391 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 0.965 |
4 | 4705 | 0.950 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
4 | 59165 | 0.900 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 391 | 2 |
1.020 | 2000 | 1 |
1.045 | 1249 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |